Literature DB >> 9714477

Polymorphisms of HLA class II genes in Japanese patients with pemphigus vulgaris.

Y Yamashina1, S Miyagawa, T Kawatsu, T Iida, I Higashimine, T Shirai, T Kaneshige.   

Abstract

Pemphigus vulgaris (PV) is an autoimmune disease mediated by autoantibodies that bind to a keratinocyte adhesion molecule, desmoglein-3. The purpose of this study was to identify critical amino acid residues of PV-associated HLA class II genes. Haplotype and allele distributions, along with molecular polymorphisms, of HLA class II genes were analyzed based on the polymerase chain reaction-restriction fragment length polymorphism in 17 Japanese PV patients. Each patient had one or two alleles of DRB1*04 (*0403, *0404, *0406) or DRB1*14 (*1401, *1405, *1406) subtypes. All DRB1*04 and DRB1*14 alleles carried by PV patients with different ethnic backgrounds reported to date, including DRB1*0402, which confers strong susceptibility to PV among Jewish populations, have amino acid residues Phe26, Leu67 or Ile67, and Val86, as well as hydrophilic amino acid residues at positions 70 and 71 of the DRB1 beta chain.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9714477     DOI: 10.1111/j.1399-0039.1998.tb03026.x

Source DB:  PubMed          Journal:  Tissue Antigens        ISSN: 0001-2815


  3 in total

1.  A systematic review and meta-analysis of HLA class II associations in patients with IgG4 autoimmunity.

Authors:  Anja Panhuber; Giovanni Lamorte; Veronica Bruno; Hakan Cetin; Wolfgang Bauer; Romana Höftberger; Astrid C Erber; Florian Frommlet; Inga Koneczny
Journal:  Sci Rep       Date:  2022-06-02       Impact factor: 4.996

2.  Modeling the bound conformation of Pemphigus vulgaris-associated peptides to MHC Class II DR and DQ alleles.

Authors:  Joo Chuan Tong; Jeff Bramson; Darja Kanduc; Selwyn Chow; Animesh A Sinha; Shoba Ranganathan
Journal:  Immunome Res       Date:  2006-01-21

3.  Association between HLA-DRB1 polymorphisms and pemphigus vulgaris: a meta-analysis.

Authors:  L Yan; J-M Wang; K Zeng
Journal:  Br J Dermatol       Date:  2012-08-20       Impact factor: 9.302

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.